BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3107546)

  • 1. Effect of prazosin and propranolol on lipoproteins of hypertensive patients.
    Hurt E; Velasco M; Silva H; Camejo G
    Biomed Biochim Acta; 1987; 46(1):111-8. PubMed ID: 3107546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prazosin and propranolol on blood lipids and lipoproteins in hypertensive patients.
    Velasco M; Hurt E; Silva H; Urbina-Quintana A; Hernández-Pieretti O; Feldstein E; Camejo G
    Am J Med; 1986 Feb; 80(2A):109-13. PubMed ID: 3080882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma lipid and lipoprotein changes in hypertensive patients treated with propranolol and prazosin.
    Gemma G; Montanari G; Suppa G; Paralovo A; Franceschini G; Mantero O; Sirtori CR
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S233-7. PubMed ID: 6177963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of bunazosin and propranolol on serum lipids and apolipoproteins in patients with essential hypertension.
    Sasaki J; Koga S; Uzawa H; Arakawa K
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):402-7. PubMed ID: 2676872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
    Sasaki J; Saku K; Ideishi M; Arakawa K; Kato Y; Kuwano E; So T
    Clin Ther; 1989; 11(2):219-24. PubMed ID: 2736568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal and gestational diabetic pregnancies. Lipids, lipoproteins and apolipoproteins.
    de Arcos F; Castelo-Branco C; Casals E; Sanllehy C; Cararach V
    J Reprod Med; 1998 Feb; 43(2):144-8. PubMed ID: 9513877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prazosin on blood lipids and on thyroid function in hypertensive patients.
    Velasco M; Silva H; Morillo J; Pellicer R; Urbina-Quintana A; Hernández-Pieretti O
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S225-7. PubMed ID: 6177961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chlorthalidone and metoprolol alone or in combination (logroton) on blood pressure, lipids, lipoproteins and circulating plasma ANF levels in essential hypertension.
    Bielmann P; Leduc G; Thibault G; Lepage J; Davignon J
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):479-85. PubMed ID: 1839902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension.
    Sacks FM; Creager MA; Gallagher SJ; Loscalzo J; Dzau VJ
    Am J Med; 1989 Jan; 86(1B):8-13. PubMed ID: 2563311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations.
    Pool JL; Lenz ML; Taylor AA
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():23-33. PubMed ID: 1979819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised two way crossover comparison of the effects of six weeks propranolol and acebutolol therapy on plasma lipid profiles in patients with hypertension or ischaemic heart disease.
    Tyagi S; Bhargava M; Bhattacharya J; Khalilullah M
    Indian Heart J; 1990; 42(2):117-9. PubMed ID: 2081608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipid levels in hypertensive patients during captopril treatment.
    Nishide T; Shirai K; Shinomiya M; Ishikawa Y; Murano S; Morisaki N; Saito Y; Yoshida S; Sasaki N
    Clin Ther; 1989; 11(6):820-7. PubMed ID: 2692824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect on lipids, lipoproteins and apoproteins of labetalol prescribed in doses of 400 mg/day in hypertensive patients. Double-blind versus placebo study].
    Rouffy J; Bakir R; Chanu B; Djian F; Goy-Loeper J; Henry Amar M; Renon D; Pappo M
    Pathol Biol (Paris); 1986 Apr; 34(4):253-8. PubMed ID: 3529000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.
    Sirtori CR; Franceschini G; Gianfranceschi G; Sirtori M; Montanari G; Tremoli E; Maderna P; Colli S; Zoppi F
    J Lab Clin Med; 1987 Sep; 110(3):279-86. PubMed ID: 3475394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta blockers and their effects on lipoproteins, phospholipids, apoproteins A and B, in whole plasma and the different fractions.
    Bielmann P; Brun D; Gagné C; Morrjani S; Jéquier JC; Bertrand M; Lupien PJ
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):259-64. PubMed ID: 6125482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
    Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
    Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.